RUPERTO, NICOLINO
RUPERTO, NICOLINO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Decision Tree Analysis as a Preliminary Evidence-Based Tool for Identifying the Syndrome of Undifferentiated Recurrent Fever in Children Compared With Hereditary Recurrent Fevers and Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome
2026 Papa, R; Bovis, F; Federici, S; Palmeri, S; Bustaffa, M; Recchi, G; Bertelli, R; Caorsi, R; Volpi, S; Fuehner, S; Cam, V; Kozakova, A; Fingerhutova, S; Insalaco, A; Foell, D; Ozen, S; Ceccherini, I; Gattorno, M; Hofer, M; Vanoni, F; Anton, J; Arostegui, J; Barron, K; Ben-Chetrit, E; Brogan, P; Cantarini, L; Ceccherini, I; De Benedetti, F; Dedeoglu, F; Demirkaya, E; Frenke, J; Goldbach-Mansky, R; Gul, A; Hentgen, V; Hoffman, H; Kallinich, T; Kone-Paut, I; Kuemmerle-Deschner, J; Lachmann, H; Laxer, R; Livneh, A; Obici, L; Rowczenio, D; Russo, R; Shinar, Y; Simon, A; Toplak, N; Touitou, I; Uziel, Y; Van Gijn, M; Kastner, D; Martini, A; Sormani, M; Ruperto, N
Environmental determinants of juvenile idiopathic arthritis: current evidence and future directions
2026 La Bella, S; Alongi, A; Filocamo, G; Cattalini, M; Lanni, S; Marino, A; Minoia, F; Ruperto, N
Ixekizumab in children with active psoriatic and enthesitis-related juvenile idiopathic arthritis (COSPIRIT-JIA): a multicentre, open-label, 16-week, Bayesian trial including a randomised reference group to adalimumab
2026 Ramanan, A; Ruperto, N; Foeldvari, I; Vega-Cornejo, G; Keller, S; Wang, R; Araujo, J; Sen, P; Marulkar, K; Tseng, J; Pitou, C; Quartier, P
Juvenile Spondyloarthritis Disease Activity Index Validation in Enthesitis-Related Arthritis and Juvenile Psoriatic Arthritis in a Prospective Clinical Trial Setting
2026 Weiss, P; Ruperto, N; Quebe-Fehling, E; Shew, A; Pricop, L; Pieterse, C; Brunner, H
Predictive value for intravenous immunoglobulin resistance of Kobayashi and Kawanet scores in 722 children with Kawasaki disease across diverse ethnic backgrounds (KIWI study): an international cohort study
2026 Mastrolia, M; Pandiarajan, V; Cattalini, M; Taddio, A; Vergnano, S; Anton, J; Sontichai, W; Sozeri, B; Ozen, S; Rosina, S; Sanchez-Manubens, J; Haviv, R; Pal, P; Fonseca, A; Gagro, A; Bagri, N; Verdoni, L; Montin, D; Maggio, M; Thangaraj, A; Pilania, R; Mosquera, M; Calzada, J; Sittiwangkul, R; Ulu, K; Balik, Z; Bilginer, Y; Garrone, M; Patrone, E; Barbi, E; Ciacci, G; Barucci, A; Ruperto, N; Simonini, G
Sex differences in clinical and imaging characteristics of axial juvenile spondyloarthritis
2026 Mayer, A; Xiao, R; Brandon, T; Weiss, P; Aggarwal, A; Burgos-Vargas, R; Colbert, R; Horneff, G; Laxer, R; Minden, K; Ravelli, A; Ruperto, N; Smith, J; Stoll, M; Tse, S; Van Den Bosch, F; Maksymowych, W; Lambert, R; Biko, D; Chauvin, N; Francavilla, M; Jaremko, J; Herregods, N; Kasapcopur, O; Yildiz, M; Srinivasalu, H; Lovell, D; Nigrovic, P; Foeldvari, I; Klein-Gitelman, M; Ozen, S; Naden, R; Hendry, A; Joos, R
Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial
2026 Brunner, H; Alexeeva, E; Bandeira, M; Carrasco, R; Chaitow, J; Chiraseveenuprapund, P; Ting, T; Erguven, M; Gottlieb, B; Oliveira, S; Patel, P; Ozen, S; Saad Magalhaes, C; Penades, I; Gruben, D; Germino, R; Posner, H; Stockert, L; Martini, A; Lovell, D; Ruperto, N
Clinical insights into heterogeneity of rheumatoid factor negative polyarticular juvenile idiopathic arthritis across the world
2025 Naddei, R; Burrone, M; Ridella, F; Uziel, Y; Trachana, M; Dolezalova, P; Rumba-Rozenfelde, I; Ruperto, N; Ravelli, A; Consolaro, A
Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial
2025 Consolaro, A; Ruperto, N; Lovell, D; Synoverska, O; Abud-Mendoza, C; Spindler, A; Vyzhga, Y; Alexeeva, E; Chaitow, J; Chiraseveenuprapund, P; Lazariciu, I; Stockert, L; Cadatal, M; Diehl, A; Brunner, H
Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project
2025 Baldo, F; Erkens, R; Mizuta, M; Rogani, G; Lucioni, F; Bracaglia, C; Foell, D; Gattorno, M; Jelusic, M; Anton, J; Brogan, P; Canna, S; Chandrakasan, S; Cron, R; De Benedetti, F; Grom, A; Heshin-Bekenstein, M; Horne, A; Khubchandani, R; Ozen, S; Quartier, P; Ravelli, A; Shimizu, M; Schulert, G; Scott, C; Sinha, R; Ruperto, N; Swart, J; Vastert, S; Minoia, F
Development and initial validation of parent and child versions of the Juvenile Arthritis Disease Activity Score
2025 Naddei, R; Ridella, F; Bovis, F; Trincianti, C; Avrusin, I; Januskeviciute, G; Burrone, M; Rebollo-Giménez, A; Minden, K; Ekelund, M; Barone, P; Rumba-Rozenfelde, I; Shafaie, N; Swart, J; Ruperto, N; Ravelli, A; Consolaro, A; Brunner, J; Fernandes, T; Appenzeller, S; Oliveira, S; Terreri, M; Tzaribachev, N; Hufnagel, M; Foeldvari, I; Horneff, G; Helling-Bakki, A; Herlin, T; Moreno, E; Anton, J; Mesa-Del-Castillo, P; Udaondo, C; Penades, I; Quartier, P; Brochard, K; Ramanan, A; Trachana, M; Orban, I; Hashkes, P; Simonini, G; Olivieri, A; Zulian, F; Montin, D; Peroni, D; Stanevicha, V; Cornejo, G; Wulffraat, N; Kamphuis, S; Gastanaga, M; Miraval, T; Oliveira-Ramos, F; Lazar, C; Nikishina, I; Alexeeva, E; Sarychev, A; Chasnyk, V; Grebenkina, L; Suwairi, W; Koskova, E; Ally, M; Louw, I; Breedt, J
Do the Provisional Paediatric Rheumatology International Trials Organisation Enthesitis/Spondylitis-Related Juvenile Idiopathic Arthritis Criteria Capture Youth With Axial Spondyloarthritis?
2025 Weiss, P; Brandon, T; Aggarwal, A; Burgos-Vargas, R; Colbert, R; Horneff, G; Laxer, R; Minden, K; Ravelli, A; Ruperto, N; Smith, J; Stoll, M; Tse, S; Van Den Bosch, F; Maksymowych, W; Lambert, R; Biko, D; Chauvin, N; Francavilla, M; Jaremko, J; Herregods, N; Kasapcopur, O; Yildiz, M; Srinivasalu, H; Hendry, A; Joos, R
Effect of Characteristic Inflammatory and Structural Pelvic Magnetic Resonance Imaging Lesions on Expert Assessment of Axial Juvenile Spondyloarthritis
2025 Mayer, A; Brandon, T; Aggarwal, A; Burgos-Vargas, R; Colbert, R; Horneff, G; Joos, R; Laxer, R; Minden, K; Ravelli, A; Ruperto, N; Smith, J; Stoll, M; Tse, S; Van den Bosch, F; Maksymowych, W; Lambert, R; Biko, D; Chauvin, N; Francavilla, M; Jaremko, J; Herregods, N; Kasapcopur, O; Yildiz, M; Srinivasalu, H; Faerber, J; Naden, R; Hendry, A; Weiss, P
Erratum: Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study (The Journal of rheumatology (2024) 51 11 DOI: 10.3899/jrheum.2024-0298.)
2025 Brunner, H; Pacheco-Tena, C; Louw, I; Vega-Cornejo, G; Alexeeva, E; Appenzeller, S; Chasnyk, V; Griffin, T; Suarez, C; Knupp-Oliveira, S; Zeft, A; Aviel, Y; De Ranieri, D; Gottlieb, B; Levy, D; Rabinovich, C; Silva, C; Spivakovsky, Y; Uziel, Y; Ringold, S; Xu, X; Leu, J; Lam, E; Wang, Y; Lovell, D; Martini, A; Ruperto, N
Factors for Consideration by Pediatric Rheumatologists When Scoring the Physician Global Assessment of Disease Activity in Juvenile Idiopathic Arthritis: First Step Toward an Internal Consensus
2025 Tarkiainen, M; Balay-Dustrude, E; Consolaro, A; Morgan, E; Ruperto, N; Rypdal, V; Backstrom, M; Vahasalo, P; Gottlieb, B
Impact of Concomitant Methotrexate Use and Prior Biologic Disease-Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial
2025 Ruperto, N; Lovell, D; Synoverska, O; Abud-Mendoza, C; Spindler, A; Vyzhga, Y; Reyhan, I; Grebenkina, L; Tirosh, I; Imundo, L; Chiraseveenuprapund, P; Kingsbury, D; Sozeri, B; Vora, S; Prahalad, S; Zholobova, E; Roberts, K; Sawyerr, G; Blum, A; Shapiro, A; Diehl, A; Ebrahim, A; Klaus, P; Martini, A; Brunner, H
Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study
2025 Bustaffa, M; Bella, S; Bayindir, Y; Amaryan, G; Gallizzi, R; Papadopoulou-Alataki, E; Fabio, G; Assalia, N; Amarilyo, G; Bakkaloglu, S; Jesenak, M; Breda, L; Anton, J; Legger, E; Alessio, M; Simonini, G; Rigante, D; Obici, L; Kuemmerle-Deschner, J; Kasapcopur, O; Insalaco, A; Glerup, M; Frenkel, J; Brunner, J; Horneff, G; Sánchez-Manubens, J; Cantarini, L; Spagnolo, A; Alataki, S; Carrabba, M; Belder, N; Porreca, A; Caorsi, R; Ruperto, N; Gattorno, M; Ozen, S
New medicines for childhood-onset systemic lupus erythematosus: an EU perspective on paediatric drug development
2025 De Lisa, R; de Andres-Trelles, F; Bax, R; Galluzzo, S; Alward, B; Thomson, A; Karres, D; Brunner, H; Ruperto, N; Egger, G
Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task force
2025 Rypdal, V; Brunner, H; Feldman, B; Ruperto, N; Aggarwal, A; Angeles-Han, S; Backstrom, M; Balay-Dustrude, E; Bracaglia, C; De Benedetti, F; Dolezalova, P; Garrone, M; Guzman, J; Horton, D; Laxer, R; Lovell, D; Lovli, T; Magni-Manzoni, S; Minoia, F; Morgan, E; Munro, J; Nordal, E; Normand, C; Pan, N; Patrone, E; Ravelli, A; Magalhaes, C; Sinha, R; Swart, J; Tarkiainen, M; Twilt, M; Vahasalo, P; Vastert, S; Vojinovic, J; Weiss, P; Gottlieb, B; Consolaro, A
Towards the definition of disease phenotypes in paediatric SAPHO syndrome: a national multicentric study
2025 Matucci-Cerinic, C; Attico, A; Malattia, C; Consolaro, A; Rosina, S; Breda, L; La Bella, S; Cattalini, M; Ricci, F; Conti, G; Civino, A; Baldini, L; Licciardi, F; Insalaco, A; La Torre, F; Pastore, S; Filocamo, G; Beretta, G; Biscaro, F; Miniaci, A; Simonini, G; Marrani, E; Pistorio, A; Ruperto, N; Volpi, S; Caorsi, R; Viglizzo, G; Gattorno, M